In the realm of oncology, the advent of clinical pathways has gained substantial traction in the past two decades as the increasing cost and complexity of cancer care demanded structured, ...
The approval of this accelerated pathway not only demonstrates the FDA’s full recognition of the quality, safety, and efficacy of the Phase 1 clinical data of hNPC01 in China, but also will ...
Ryan Haumschild, PharmD, MS, MBA: Dr Zeidan, what are your thoughts on clinical pathways? Because clinical pathways are getting used more and more. Dr Weaver brought that up. But for a unique patient ...
As healthcare becomes more entrenched in the digital revolution, the need for an approved set of protocols for care delivery — clinical pathways — is becoming increasingly critical. Clinical pathways, ...
Pasithea Therapeutics Corp. has announced the successful enrollment and initial dosing of three subjects in Cohort 6 of its Phase 1 clinical trial for PAS-004, a candidate for treating ...
We are grateful for the collaborative feedback from FDA on the Gemini program, which provides us a clear and expedient path forward for seeking approval of Gemini as a treatment for AKI,” said, James ...
Raymond Thertulien, MD, PhD, highlights provider incentives for adherence to MM treatment pathways. Ryan Haumschild, PharmD, MS, MBA: You talked about adherence to pathways. That’s an important ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results